PCN264 Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin in Combination with Daunorubicin and Cytarabine for the Treatment of Acute Myeloid Leukaemia in Portugal
| Autor: | Paquete, A.T., Inês, M., Borges, M., Silva Miguel, L. |
|---|---|
| Zdroj: | In Value in Health December 2020 23 Supplement 2:S469-S470 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect